Company & Sponsor Intelligence

Florida State University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials6

Recruiting1

Completed5

Countries1

Therapeutic footprint

alzheimersautismdepressionparkinsonssubstance_use

Indexed studies

NCT06132581Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
depression · United StatesNA

NCT03575429Autism Adaptive Community-based Treatment to Improve Outcomes Using Navigators (ACTION) Network
autism · United StatesNA

NCT04899934Feasibility of Mobile and Technology Assisted Aftercare Services for Crisis Stabilization Units
substance_use · United StatesNA

NCT04834765Mindfulness-Based Art Therapy and Generation Z
depression · United StatesNA

NCT02184494Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
parkinsons · United StatesNA

NCT02697721Powerful Tools for Caregivers of Dementia Patients
alzheimers · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →